Hipomielinização em cães Weimaraner: relato de caso Hypomielination in Weimaraner dogs: case report

Três cães, fêmeas, da raça Weimaraner apresentaram tremores corporais rítmicos generalizados a partir da primeira semana de vida. Outros dois cães, machos, da mesma ninhada não apresentaram alterações. Uma fêmea com quatro semanas de idade foi submetida à eutanásia e necropsiada. Macroscopicamente, observou-se no encéfalo pouca demarcação da substância branca em relação à cinzenta. Histologicamente havia acentuada vacuolização de toda a substância branca subcortical. A mielinização no sistema nervoso periférico estava normal. Os sinais clínicos, a idade de ocorrência e as lesões histológicas são compatíveis com a hipomielinogênese congênita descrita em cães.<br>Three female Weimaraner pups had generalized and rhythmic body tremors since the first week of age. The remaining two male littermates were unaffected. One 4-week-old female was euthanatized and necropsied. On gross examination, poor demarcation between the gray and white matter was observed. Microscopically, there was severe hypomyelination of the brain compatible with congenital hypomyelinogenesis reported in dogs

A novel mutation in the proteolipid protein gene leading to Pelizaeus-Merzbacher disease.

Point mutations of the gene of human proteolipid protein (PLP) have been recognized as the molecular basis of one form of leukodystrophy, the X-chromosome-linked Pelizaeus-Merzbacher disease (PMD). We report the molecular analysis of four PMD patients in three unrelated families and describe a point mutation (G-->A transition) in exon V which leads to the substitution of Gly216 by a serine residue in a highly conserved extracytosolic domain and a Mae I RFLP. Molecular modelling with energy minimization indicates that this seemingly minor alteration of the amino-acid sequence induces a considerable conformational change and tight packing of the polypeptide chain apparently not compatible with the regular PLP function in oligodendrocytes. This mutation has been detected and characterized by PCR amplification of genomic DNA using intron and exon primers and the complete sequence analysis of the seven exons and a 300 bp promoter region of the PLP gene of two affected brothers. The sequence analysis of a PCR fragment representing exon V amplified from genomic DNA of different kindreds of the pedigree revealed the mother as the only carrier indicating that the mutation has occurred de novo in the mother's germline. PLP gene (including the 8.8 kb intron I) rearrangements have been excluded by Southern blot hybridization and overlapping PCR amplification of genomic DNA